C. Will Heise, MD

CredibleMeds now includes information from FDA drug labels to inform prescribers of any ECG monitoring recommendations, warnings for use in congenital long QT and any contraindicated concomitant drugs.

The QT interval on the ECG is recognized as an independent predictor of cardiac mortality and a sensitive, but relatively nonspecific, predictor of drug-induced torsades de pointes.